Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|
Gross Profit | $62.4M | $134.3M | $201.5M | $237.0M | $302.1M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, LifeStance Health Group, Inc.'s last 12-month Gross Profit is $312.9M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, LifeStance Health Group, Inc.'s Gross Profit growth was 11.2%. The average annual Gross Profit growth rates for LifeStance Health Group, Inc. have been 33.9% over the past three years, 70.9% over the past five years.
Over the last year, LifeStance Health Group, Inc.'s Gross Profit growth was 11.2%, which is higher than industry growth of 0.0%. It indicates that LifeStance Health Group, Inc.'s Gross Profit growth is Good.